Add to ORKGIn an open, crossover study of 12 patients of mean age 74 (range 64-88) who required perioperative prophylactic antibiotic therapy, cefodizime was administered as a single iv infusion of 1 g, and repeated infusions of 1 g twice daily for 4-5 days. Serum and urine concentrations of cefodizime were determined by high performance liquid chromatography. The following pharmacokinetic indices were estimated afte
The steady-state pharmacokinetics of cefepime were evaluated in 10 middle-aged and elderly patients ...
PURPOSE: To characterise the pharmacokinetics and associated variability of cefotaxime in adult inte...
The pharmacokinetics of cefepime were studied in 10 male patients receiving continuous ambulatory pe...
In young adults, the elimination half-life of cefodizime is 3-5-4 h. A pharmacokinetic study was per...
The phannacokinetics of cefixime were compared in 12 young and 12 elderly subjects receiving 400 mg ...
The i.v. and i.m. dose pharmacokinetics of ceftazidime 1 g b.i.d. were investigated in steady state ...
The pharmacokinetics of cefodizime, a new expanded-spectrum cephalosporin for parenteral use, was st...
The pharmacokinetics and absolute bioavailability of cefodizime were determined after iv and im admi...
The steady-state pharmacokinetics of cefepime were evaluated in 10 middle-aged and elderly patients ...
Ceftizoxime is a widely used beta-lactam antimicrobial agent, but pharmacokinetic data for use with ...
The pharmacokinetic profile of cefepime following single and repeated iv or im administration was ev...
We investigated the pharmacokinetics of non-metabolized cefotaxime in 10 patients undergoing CAPD. T...
Pharmacokinetics of cefpodoxime, an extended-spectrum cephalosporin, were determined for eight nonin...
Thirty-six urological patients (21 male, 15 female) aged 21 to 83 years with complicated and/or hosp...
Ciprofloxacin is a fluoroquinolone antibiotic effective in the treatment of lower respiratory tract ...
The steady-state pharmacokinetics of cefepime were evaluated in 10 middle-aged and elderly patients ...
PURPOSE: To characterise the pharmacokinetics and associated variability of cefotaxime in adult inte...
The pharmacokinetics of cefepime were studied in 10 male patients receiving continuous ambulatory pe...
In young adults, the elimination half-life of cefodizime is 3-5-4 h. A pharmacokinetic study was per...
The phannacokinetics of cefixime were compared in 12 young and 12 elderly subjects receiving 400 mg ...
The i.v. and i.m. dose pharmacokinetics of ceftazidime 1 g b.i.d. were investigated in steady state ...
The pharmacokinetics of cefodizime, a new expanded-spectrum cephalosporin for parenteral use, was st...
The pharmacokinetics and absolute bioavailability of cefodizime were determined after iv and im admi...
The steady-state pharmacokinetics of cefepime were evaluated in 10 middle-aged and elderly patients ...
Ceftizoxime is a widely used beta-lactam antimicrobial agent, but pharmacokinetic data for use with ...
The pharmacokinetic profile of cefepime following single and repeated iv or im administration was ev...
We investigated the pharmacokinetics of non-metabolized cefotaxime in 10 patients undergoing CAPD. T...
Pharmacokinetics of cefpodoxime, an extended-spectrum cephalosporin, were determined for eight nonin...
Thirty-six urological patients (21 male, 15 female) aged 21 to 83 years with complicated and/or hosp...
Ciprofloxacin is a fluoroquinolone antibiotic effective in the treatment of lower respiratory tract ...
The steady-state pharmacokinetics of cefepime were evaluated in 10 middle-aged and elderly patients ...
PURPOSE: To characterise the pharmacokinetics and associated variability of cefotaxime in adult inte...
The pharmacokinetics of cefepime were studied in 10 male patients receiving continuous ambulatory pe...